Fresenius | FRE - Current Liabilities



Fresenius reported EUR8.3B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Akzo Nobel EUR 5.16B 371M Jun/2025
Alcon AG USD 2.42B 178M Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
BASF EUR 18.18B 74M Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Beiersdorf EUR 3.77B 6.12B Jun/2025
DaVita Healthcare Partners USD 2.93B 26.76M Jun/2025
Demant DKK 5.79B 301M Jun/2025
E.ON EUR 28.09B 503M Jun/2025
Essilor EUR 11.39B 832M Jun/2025
Fresenius EUR 8.3B 33M Jun/2025
Fresenius Medical Care EUR 5.66B 213.7M Jun/2025
Getinge SEK 15.05B 169M Dec/2024
Givaudan CHF 2.97B 911M Jun/2024
GlaxoSmithKline GBP 20.38B 453M Jun/2025
GN Store Nord DKK 7.89B 5M Jun/2025
GRIFOLS EUR 1.99B 180.07M Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 9.86B 357M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Philips EUR 7.2B 445M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
RWE EUR 23.44B 1.27B Jun/2025
Sanofi 29.06B 3.16B Jun/2025
Smith & Nephew USD 1.54B 10M Jun/2025